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ABSTRACT 
Technologies that allow the efficient chemical modification of proteins under mild conditions are 
widely sought after. Sortase-mediated peptide ligation provides a strategy for modifying the N- or C-
termini of proteins. This protocol describes the use of depsipeptide substrates (containing an ester 
linkage) for sortase A (SrtA) to completely modify proteins carrying a single N-terminal glycine residue 
under mild conditions in 4-6 hours. The SrtA-mediated ligation reaction is reversible, so most labelling 
protocols using this enzyme require a large excess of both substrate and sortase to produce high yields 
of ligation product. In contrast, switching to depsipeptide substrates effectively renders the reaction 
irreversible allowing complete labelling of proteins with a small excess of substrate and catalytic 
quantities of sortase. Herein, we describe the synthesis of depsipeptide substrates that contain an ester 
linkage between a threonine and glycolic acid residue and an N-terminal FITC fluorophore appended 
via a thiourea linkage. 
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INTRODUCTION  
Chemical modification of proteins is widely used to optimise the properties of biopharmaceuticals and 
also provides chemical biologists with powerful strategies with which to study the molecular basis for 
life.  It is essential that protein modification strategies are robust and efficient. Common strategies 
including: alkyne-azide cycloadditions1,2, Staudinger ligation3,4, maleimide conjugation etc., and all 
have associated challenges and limitations. For example, the necessity to incorporate non-natural amino 
acid residues into the protein to be labelled5, the non-trivial synthesis of labelling reagents; risk of non-
specific modification to the protein6, and typically a requirement for a large excesses of reagents to 
ensure successful couplings. Herein, we report an optimised protocol that utilises Sortase and 
depsipeptide substrates to allow the efficient modification of proteins. 
Sortases are a class of transpeptidase enzymes that are responsible for ³sorting´ and covalently 
anchoring virulence factors to the cell wall of gram-postive bacteria7,8. Sortase A (SrtA) is a type II 
membrane protein, native to Staphylococcus aureus, that ligates proteins carrying an LPXTG 
recognition motif to peptidoglycan substrates harbouring an N-terminal oligoglycine sequence9. The 
catalytic cysteine residue located in the active site of SrtA cleaves the amide bond between the threonine 
and glycine residues of the LPXTG substrate to form a thioacyl-enzyme intermediate10. The 
intermediate is then attacked by the oligoglycine substrate to form a new ligated product. 
The advantage of using SrtA as a tool for protein modification became apparent once the catalytic core 
of the enzyme had been heterologously expressed nearly 15 years ago7,9.  Since then the enzyme has 
been used extensively to modify proteins at both the N- and C-termini with a large variety of different 
labels11,12; including, biotin,13 GPI mimics14, fluorescent tags,13 PEG chains15  and other biologically 
important molecules 16,17. The vast majority of examples of sortase-mediated ligation have used 
synthetic N-terminal oligoglycine peptides to label proteins harbouring a flexible C-terminal LPXTG 
motif. Alternatively, this approach can be reversed to allow the modification of proteins carrying an N-
terminal oligoglycine sequence under the same mild conditions18,19.   However, as the ligation reaction 
is reversible, a large excess of labelling reagent is normally required to achieve high levels of protein 
modification, which may not always be desirable or possible. The reaction can be rendered effectively 
irreversible if the scissile peptide bond (i.e. the amide bond between the threonine and glycine residues) 
is replaced by an ester linkage (Figure 1A).20 In this regard, a methyl ester of the desired peptide can be 
used as a substrate for the N-terminal protein ligation; however, a high concentration of SrtA and a 
large excess of methyl ester labelling reagent are required to achieve a high ligation yield.  
Figure 1: A) SrtA substrate variants. X = Any amino acid. B) SrtA-mediated modification of proteins 
using depsipeptide substrates. 
In our laboratory, we have found that depsipeptide substrates can provide a more efficient approach to 
achieve quantitative labelling of proteins carrying a single N-terminal glycine residue (Figure 1B)21. 
The efficiency of the SrtA-mediated ligation reaction is significantly improved when using depsipeptide 
substrates such that typically only 1.5-3 molar equivalents of label and 0.1-0.2 molar equivalents of 
SrtA are required to completely modify proteins. Conversely, protocols for N-terminal labelling with 
unmodified peptides stipulate 20-50 equivalents of peptides and 2-3 equivalents of SrtA22. If the label 
is precious and/or difficult to acquire, this ability to maximise the yield of protein modification is highly 
desirable.  
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Synthesis of the depsipeptide amino acid 
The protected depsipeptide amino acid is synthesised in two solution-phase steps in high yield (Figure 
2): alkylation of a commercially available Fmoc-threonine derivative followed by hydrogenolysis of 
the C-terminal benzyl ester group. Although both synthetic steps are relatively simple, the 
hydrogenolysis of the benzyl protecting group requires careful monitoring. The resulting depsipeptide 
amino acid can be incorporated into a growing peptide chain using standard solid phase peptide 
synthesis (SPPS) methodologies to produce depsipeptide substrates for SrtA (Figure 2). Resins having 
2-chlorotrityl or Rink amide linkers both provide high yields of depsipeptides21.  
          
Figure 2: Synthetic route to depsipeptide substrates via Fmoc depsipeptide building block 3. R1, R2 = 
any amino acid; DIPEA = diisopropylethylamine; TBAI = tetrabutylammonium iodide; THF = 
tetrahydrofuran; SPPS = solid phase peptide synthesis; TFA = trifluoroacetic acid. 
We describe the synthesis on a 10 g scale, but there is no practical reason why this could not be scaled 
up or down by a factor of 2-5. The reaction thermodynamics have not however been thoroughly 
investigated so we would not recommend that larger scale reactions are attempted by non-specialists.  
This synthetic strategy could feasibly be used to link any commercially available Fmoc-protected amino 
acid with glycolic acid to form a range of depsipeptide substrates. This was first demonstrated by Suich 
et al.23 to make an Fmoc-Tyr(OtBu)-Gc-OH amino acid. Replacement of the glycine-mimicking 
analogue, glycolic acid is also feasible but would be dependent upon the availability of suitably-
protected enantiomerically-enriched D-bromoalkanoic acids. 
Depsipeptide incorporation into the peptide  
The use of SPPS to prepare the depsipeptide substrate enables easy incorporation of a wide range of 
labels (e.g., fluorophores, affinity tags, bioorthogonal reactive groups), and, in general, the resulting 
structures are limited only by the availability of SPPS-compatible building blocks. The depsipeptide 
substrates can then be used directly to transform proteins carrying an N-terminal glycine residue under 
mild aqueous conditions within 4-6 hours.  
Protein labeling 
While only one glycine residue is necessary for ligation to occur successfully, it is essential that the 
glycine residue is sterically unhindered; typically a spacer of 3-4 amino acid residues from a globular 
domain is sufficient to allow ligation to occur. While a competing hydrolysis reaction may occur upon 
extended incubation with sortase, high ligation yields can usually be achieved with substrate protein 
concentrations >50 PM and 1.5-3 equivalents of depsipeptide label. Incorporation of an N-terminal 
glycine residue into a protein can be achieved in a number of different ways. For example, proteins are 
always expressed with either a methionine or an N-formylmethionine at their N-terminus, which is 
usually removed in vivo. In principle, a given protein¶s gene sequence could be modified to incorporate 
a glycine as the second N-terminal amino acid, which would be exposed after the methionine is lost. 
Alternatively, periplasmic targeting sequences can be designed to leave an N-terminal glycine residue 
once the sequence has been removed during co-translational protein export into the periplasm24. A third 
in vitro approach would be to engineer a suitable protease (e.g. TEV or Factor Xa) recognition sequence 
immediately before a glycine residue  that would allow the release of a protein carrying an N-terminal 
glycine residue once the cleavage event has taken place.  
In this protocol we describe detailed conditions for the synthesis of the required depsipeptide building 
block, the synthesis of an example labelling peptide using an N-terminal thiourea, and an example of 
the labelling of a galactose-binding variant of mannose-binding protein (gMBP). These protocols are 
freely adaptable for the preparation and labelling of any protein containing an N-terminal glycine and 
with essentially any material which can be chemically conjugated to the labelling peptide. 
MATERIALS 
CRITICAL All solvents used for reactions should be of the highest quality possible. Solvents for 
extractions and reaction workup should be at least reagent grade. All manipulations should be carried 
out in a fume hood. Solid and liquid waste generated must be disposed of in accordance with local 
environmental regulations. 
 
REAGENTS: 
x Fmoc-amino acids (Sigma Aldrich, VWR International or Cambridge Bioscience) 
x Gly-2-Cl-trityl resin (Sigma, 92681-1G-F) 
x O-(6-Chlorobenzotriazol-1-yl)-N,N,NƍNƍ-tetramethyluronium hexafluorophosphate (HCTU) 
(Sigma Aldrich, 04936-25G-F) 
x N,N-Diisopropylethylamine (DIPEA) (Sigma Aldrich, 550043-100ML)  
x Fluorescein isothiocyanate isomer I (FITC) (Sigma Aldrich, F7250-1G)   
x Trifluoroacetic acid (TFA) (Sigma Aldrich T6508-500ML) 
x Triisopropylsilane (TIS) (Sigma Aldrich, 233781-10G) 
x Benzyl 2-bromoacetate (Sigma Aldrich, 245631-50G) 
x Tetrabutylammonium iodide (Sigma Aldrich, 86890-25G) 
x Piperidine (Sigma Aldrich, 104094-2.5L) 
x Triethylamine (Sigma Aldrich, 471283-100ML) 
x Palladium on carbon (10 wt%) (Sigma Aldrich, 520888-10G) 
x DMF (Sigma Aldrich,33120-2.5L) 
x MeOH (Sigma Aldrich,33213-2.5L) 
x THF(Sigma Aldrich, 34865-2.5L)  
x EtOAc (VWR International, 23880.324) 
x CH2Cl2 (VWR International, 23373.320)  
x Acetonitrile (VWR International, 20060.320)  
x Hexane (Sigma Aldrich, 34859-2.5L) 
x Ether (VWR International, 83624.320)  
x 1,4 dioxane (Sigma Aldrich, 360481-500ML) 
x AcOH (Sigma Aldrich, 27221-2.5L) 
x Geduran Si 60 for column chromatography (VWR International  1.11567.1000) 
x Celite 577 fine (Sigma Aldrich, 22142-1KG) 
x Sodium chloride (Sigma Aldrich, S5886-500G) 
x Sodium thiosulfate (Sigma Aldrich, 217263-1KG) 
x HEPES salts (Fisher Scientific Ltd, BPE310-1) 
x CaCl2 (Sigma Aldrich, C4901-1KG) 
x Recombinant Sortase A from Staphylococcus aureus (We recommend a protocol similar to that 
described by Guimares et al.25except that we recommend that protein concentration is estimated 
using the UV absorption at 280 nm (theoretical extinction coefficient H280 = 17420 cm-1 M-1) 
REAGENT SETUP 
Prepare a saturated aqueous solution of sodium chloride.  Weigh approximately 400 g sodium chloride 
and add to a 1 L storage bottle. Fill the bottle to the 900 mL mark and shake to dissolve the sodium 
chloride. As the sodium chloride dissolves, top up the bottle to the 1 L mark. Approximately 10% of 
the sodium chloride will remain undissolved. Allow this to settle upon storage. 
Prepare a 10% wt/vol solution of sodium thiosulfate. Weigh out 100g of sodium thiosulfate and add to 
a 1 L measuring beaker with a Teflon magnetic stirrer. Fill the measuring beaker to the 800 ml and stir 
the solution for 2-3 minutes until all the solid has dissolved. Fill the beaker to the 1 L mark with 
deionised water. Store the solution in a 1 L storage bottle. 
Prepare ligation buffer. Weigh out HEPES (11.90 g), NaCl (8.70 g) and CaCl2 (0.55 g) and add to a 1 
L measuring beaker with a Teflon magnetic stirrer. Fill the measuring beaker up to the 800 ml mark 
with deionised water and stir the solution for 2-3 minutes until all the solid has dissolved. Adjust the 
pH of the solution to pH 7.50 by slowly adding NaOH solution (5 mM) with a pipette.  Fill the beaker 
up to the 1 L mark with deionised water. The ligation buffer will consist of HEPES (50 mM), CaCl2 (5 
mM) and NaCl (150 mM) at pH 7.5. Store in a 1 L storage bottle for up to 3 weeks. 
EQUIPMENT 
x Fritted polypropylene tubes (10 ml) (Grace and Co) 
x Stuart SB tube rotator 
x Centrifuge 
x Incubator  
x NMR spectrometer 
x Mass spec  
x HPLC 
x Rotary evaporator 
x Single-neck round-bottom flasks (25±500 ml) 
x 500 ml to 1 liter glass chromatography column (diameter >3 cm) 
x Magnetic stir bars 
x Hotplate/magnetic stirrer 
x Separation funnels (500 ml to 1 liter) 
x Storage bottles (1 liter) 
x Freezer dryer  
x High vacuum pump 
x Water pump  
x Vacuum manifold  
x Thick walled balloon gas container connected to a two-way stopcock adapter with Luer fittings  
x TLC plates  
x 500 ml Buchner flask 
x 14 ml neutral-glass sample tube 
x Gilson p200 pipette 
x 7 cm inner diameter fritted glass funnel 
EQUIPMENT SETUP 
HPLC Peptides are analysed using an Agilent 1290 affinity LC system equipped with an Ascentis 
Express 10 cm × PPȝP(6-&SHSWLGHFROXPQPOPLQí and UV detection at 220 nm 
- 280 nm. Gradient from 0.1% TFA/5% MeCN (vol/vol) in H2O to 0.1% TFA/95% MeCN in H2O over 
5 min 40 s.  
HRMS Protein MS analysis is carried out using a Bruker HCT Ultra MS system equipped with an 
Agilent 1200 series  autosampler. Protein is directly injected into the instrument after dilution in 0.1% 
TFA/50% MeCN in H2O. 
PROCEDURE 
Stage 1: Synthesis of the precursor. Preparation of Fmoc-Thr(OtBu)-Gc-OBn  ƔTIMING: 19 h 
(overnight step) 
1) Add 20 ml of THF to a 100 ml round bottom flask equipped with a magnetic stirrer bar. To this 
flask add sequentially 10 g (25 mmol) of Fmoc-Thr(tBu)-OH, 5.9 ml (38 mmol) of benzyl 2-
bromoacetate and a catalytic amount of tetrabutylammonium iodide (3.7 g, 10 mmol) before adding 5.2 
ml (30 mmol) of triethylamine. Stir the reaction mixture overnight at room temperature (18-25 °C). 
After a few minutes of stirring the solution will turn yellow and a solid should be seen to precipitate. 
2) The following day, pour the reaction mixture into a 500 ml separating funnel and wash the flask 
out with 200 ml deionised H2O and extract the crude product with 2 × 200 ml of ethyl acetate.  
3)  Combine the ethyl acetate extracts and wash in a 1 L separating funnel with 2 × 400 ml of 10% 
(wt/vol) sodium thiosulfate solution and 400 ml of saturated NaCl solution. Collect the ethyl acetate 
layer and  add anhydrous sodium sulfate in approx. 3 g portions until the solid stops clumping together 
to ensure the solution is dry. Filter the mixture and reduce the filtrate to dryness by rotary evaporation 
at 40 °C (approx 4.0 Torr). The residue will be a yellow oil. 
Purification of Fmoc-Thr(OtBu)-Gc-Obn by chromotgraphy ƔTIMING: 2 h  
4) Prepare a silica gel slurry by adding 300 ml of a 4:1 mixture of hexane/ethyl acetate to approx. 
250 g silica gel 60A (40-60 µm particle size). The slurry should be added to a column with a 4.5-5 cm 
inner diameter and the column should be packed until the compressed silica layer reaches 30-35 cm in 
height.   
5) Dissolve the crude product in a minimal volume of CH2Cl2. Apply to the column and elute with 
a 4:1 mixture of hexane/ethyl acetate. Collect fractions of 15-20 ml and analyse by thin-layer 
chromatography. The desired product can be visualised under a UV lamp and it should have an Rf of 
0.53 in a mixture of 2:1 hexane/ethyl acetate. To speed up the elution of the product the solvent system 
may be ramped up to a 1:1 mixture of hexane/ethyl acetate after the product is initially detected. 
7) Combine fractions containing the product and reduce these to dryness by rotary evaporation at 
40 °C (approx 4.0 Torr) to leave a slightly coloured oil as the product. Dry the product to remove 
residual solvent using a high vacuum line (0.1 Torr) and store at -20 °C. The oil will form a glassy solid.  
Starting with 10 g of Fmoc-Thr(OtBu) will typically produce 13 g of product. 
Preparation of Fmoc-Thr(OtBu)-Gc-OH  ƔTiming: 1-6 h  
8) Add 12 ml of THF to a 100 ml round bottom flask equipped with a magnetic stirrer bar. To this 
flask add 1.0 g of Fmoc-Thr(OtBu)-Gc-OBn (1.80 mmol) and stir the solution until all the solid has 
dissolved before slowly adding 4 ml of H2O. To the stirred solution add 100 mg of palladium on carbon 
(10 wt%) and seal the flask with an appropriate sized rubber Suba-seal.  
9) Fit a two-way stopcock with Luer fittings to a thick-walled balloon and fill it with hydrogen. 
Attach a needle to the stopcock using the Luer fitting and insert the needle into the reaction vessel 
through the suba-seal. 
! CAUTION: Hydrogen gas is extremely flammable and should be handled with extreme care in a 
ventilated fume hood fitted with blast shield. Inexperienced users must consult their safety advisor on 
the local rules for handling and dispensing hydrogen before attempting this part of the protocol. 
Additional portions of the palladium on carbon catalyst must not be added to the system under hydrogen 
gas since it may spontaneously ignite.. 
10) Evacuate the air from the reaction vessel and purge three times with hydrogen. Stir the reaction 
mixture at room temperature under hydrogen for 1-6 h. Refill the balloon if necessary. 
11) Remove 5-15 µL samples using a needle to allow the reaction to be monitored by TLC (4:1 
hexane/ethyl acetate, 1% AcOH). The desired product should have an Rf of 0.23 in 23 in this solvent 
mixture.  
ǻ&5,7,&$/67(3The hydrogenation step should be monitored carefully and if the reaction is very 
close or at completion it should be stopped immediately. Leaving the hydrogenation for prolonged 
periods will cause cleavage of the Fmoc protecting group making the subsequent purification step more 
difficult. The Fmoc cleavage byproduct will have an Rf of 0.78 in a mixture of 2:1 hexane/ethyl acetate 
12) Once the reaction is complete the reaction vessel is purged with nitrogen and opened to the 
atmosphere.  
 13) Pack a pad of Celite (approx. 13 g) suspended in THF on a 7 cm inner diameter fritted glass 
funnel (approx. 3 cm high). Connect the funnel to a 500 ml Büchner flask attached to a water pump. 
Under reduced pressure wash the Celite pad with a mixture of 3:1 THF/H2O until the filtration solution 
is clear and free from contaminants.   
14) Filter the reaction mixture through the pad of Celite and wash twice with a 100 ml of 3:1 
THF/H2O solution.  
15)  Transfer the filtrate to a 500 ml round bottom flask and remove the solvent under 
reduced pressure using a rotary evaporator at 40 °C (approx 4.0 Torr). The crude product is obtained as 
an off-white foamy solid. 
ƒ PAUSE POINT: If no Fmoc-cleavage was detected during steps 10-11  then the crude product can 
be used without further purification. In this case, proceed to step 19.  Trace amounts of Fmoc-
Thr(OtBu)-Gc-OBn starting material does not appear to interfere with the solid phase peptide synthesis 
If Fmoc cleavage has occurred the crude product can be stored at least 3-4 days at - 20 °C before further 
purification is carried out.     
Purification of Fmoc-Thr(OtBu)-Gc-OH  TIMING: 2-3 h; plus, overnight freeze drying  
16) Prepare a silica gel slurry by adding 100 ml of a 9:1 mixture of CH2Cl2/MeOH to appox. 40 g 
of silica gel 60A (40-60 µm particle size). The slurry should be added to a column with a 3.5-4.0 cm 
inner diameter and the column should be packed until the compressed silica layer reaches 18-22 cm in 
height.   
17) Dissolve the crude product in a minimal volume of CH2Cl2. Apply to the column and elute with 
9:1 mixture of CH2Cl2/MeOH. Collect fractions of 5-10 ml and analyse by thin-layer chromatography. 
The desired product should have an Rf of 0.63 in a mixture of 9:1 CH2Cl2/MeOH and 1% AcOH.  
18) Combine the elution fractions and concentrate to dryness using a rotary evaporator at 40 °C 
(approx 4.0 Torr) to leave a foamy white solid as the product.  
19) The white solid is then dissolved in acetonitrile and freeze dried overnight to leave a white 
fluffy solid. Starting with 1.0 g of Fmoc-Thr(OtBu)-Gc-OBn it is possible to obtain ca. 700 mg of 
product. 
ƒ PAUSE POINT: The Fmoc-Thr(OtBu)-Gc-OH can be stored for at least a month at -20 °C 
Part 2: Preparation of depsipeptides. Presynthesis preparation. TIMING 5 min 
20) Prepare a 250 ml stock solution of 20% piperidine (v/v) in DMF for the removal of the Fmoc 
group and store in a screw capped glass bottle. 
Resin preparation. TIMING: 30 min 
21) Weigh 100 mg of Gly-2-Cl-trityl resin (0.11 mmol, loading capacity: 1.1 mmol g-1) directly 
into a fritted 8 ml polypropylene reservoir fitted with a 2-way stopcock. 
22) Add 6 ml of DMF to the resin, cap the reservoir and allow the resin to swell by rotation on a 
Stuart rotator tube spinner for 20 minutes.  
LPETGcG depsipeptide synthesis. TIMING: 1 days 
23) Weigh out 5 equivalents of Fmoc-Thr(OtBu)-Gc-OH (250 mg, 0.55 mmol) and 4.9 equivalents 
of HCTU (228 mg, 0.54 mmol) into a single 14 ml neutral-glass sample tube. 
24) Dissolve the reagents in 4 ml of DMF and add 10 equivalents of DIPEA (203 µL, 1.10 mmol) 
to the solution. Mix the sample using a vortex mixer to ensure all the compounds are dissolved. After 
the addition of DIPEA the solution should turn a dark yellow/orange.    
25) Connect the reservoir to a vacuum manifold and drain the DMF from the pre-swollen resin.  
26) Add the amino acid solution to the pre-swollen resin and rotate for 1 h  
27) Once an hour has elapsed, drain the amino acid solution from the resin using the vacuum 
manifold. Add 4 ml of DMF to the resin and agitate the resin by rotation for 2 minutes. Drain the DMF 
and repeat the procedure twice.  
28) Remove the Fmoc group from the resin by rotating in 4 ml of 20% (v/v) piperidine/DMF 
solution for 2 minutes. Drain the cleavage mixture and repeat the procedure four more times.   
29) Wash the resin thoroughly by rotating in 6 ml of DMF for 2 minutes. Drain the DMF and repeat 
the procedure four more times. 
ǻ&5,7,&$/67(3It is imperative that all the residual piperidine is removed as it can interfere with 
the subsequent coupling step.    
30) Repeat steps  23-29, substituting Fmoc-Thr(OtBu)-Gc-OH with Fmoc-Glu(OtBu)-OH.  
31)  Repeat steps 23-29, substituting Fmoc-Thr(OtBu)-Gc-OH with Fmoc-Pro-OH. 
32) Repeat steps 23-27 using Fmoc-Leu-OH. 
33) Repeat the coupling of Fmoc-Leu-OH by repeating steps 23-29to ensure maximum coupling 
efficiency to the slightly hindered proline residue.  
34) Wash the resin by rotating in 4 ml of DMF for 2 minutes. Drain the DMF and repeat this wash 
step twice. 
35) Wash the resin further by rotating in 4 ml of CH2Cl2 for 2 minutes. Drain the DCM and repeat 
this wash step twice. 
36) Shrink the resin by rotating in 6 ml of MeOH for 2 minutes. Drain the MeOH and repeat this 
shrinking step twice. Leave the resin to partially dry for 15 minutes by exposing the reservoir to reduced 
pressure on the vacuum manifold. 
37) Place the reservoir under high vacuum (0.1 Torr) for at least 3 hours to completely dry the resin.   
ƒ PAUSE POINT: The reservoir containing the dry depsipeptide-loaded resin can be sealed with 
parafilm and stored at ± 20 °C for several months.  
Peptide elongation. TIMING: Variable  
38) Swell the depsipeptide-loaded resin by adding 6 ml of DMF and rotating for 20 minutes.  
39) Repeat step 23-29with the desired Fmoc protected amino acid. 
N-terminal fluorescent labelling using isothiocyanates  TIMING: 20 h (overnight step) 
40) Repeat step 23-29 using Fmoc-GABA-OH. 
41) Weigh out 6 equivalents of FITC (219 mg, 0.66 mmol) into a 14 ml neutral-glass sample tube. 
42) Dissolve the FITC in 900 µl of DMF and add 14 equivalents of DIPEA (319 µL, 1.54 mmol).  
ǻ&5,7,&$/67(3It is important to dissolve the FITC in the minimal amount of solvent, as the 
coupling efficiency to the peptide is concentration dependent. FITC is more soluble once the DIPEA 
has been added, so ensure the solution is well mixed once all reagents have been added.  
43) Add the FITC solution to the resin and rotate overnight at room temperature (18-25 °C)  
ǻ&5,7,&$/67(3Completely cover the peptide reservoir in aluminium foil to protect the reaction 
from light.    
ƒ PAUSE POINT: The FITC-peptide conjugation is left overnight  
44) The next day drain the FITC solution from the resin. Wash the resin thoroughly by rotating in 
6 ml of DMF for 2 minutes. Drain the DMF and repeat the procedure four more times.  
45) Repeat steps 15-18. 
Depsipeptide cleavage TIMING: 20 h (overnight step) 
46) Prepare a 3 ml cleavage-cocktail consisting of TFA:H2O:TIS (95:2.5:2.5) in a 14 ml neutral-
glass sample tube. 
! CAUTION: TFA is a corrosive volatile solution and should only be handled in a fume hood with 
suitable ventilation.  
47) Transfer 2 ml of the cleavage-cocktail to the dried resin and rotate for 2 hours to cleave the 
depsipeptide.  
48) While the depsipeptide is being cleaved add 40 ml of ether to a falcon tube and cool it to -20 
°C.  
49) After 2 hours drain the cleavage cocktail into the pre-prepared cold ether to precipitate the 
depsipeptide. Store the ether suspension at -20 °C until step 51. 
50) Transfer the remaining 1 ml of cleavage-cocktail to the resin and rotate for a further 5 minutes 
to ensure all the depsipeptide is removed the resin.  
51) Drain the residual cleavage cocktail into the cold ether to precipitate any remaining 
depsipeptide. 
52) Pellet the cleaved depsipeptide by centrifuging the ether layer for 10 minutes at 4000 × g. 
53) Decant off the ether layer and resuspended the depsipeptide pellet in 40 ml of cold ether.  Mix 
the sample using a vortex mixer to ensure complete resuspension and centrifuge for 10 minutes at 
4000 × g. Repeat twice.  
54) Decant off the ether layer and remove any residual ether with a glass pipette. Leave the 
depsipeptide pellet exposed to the atmosphere for one hour to ensure it is almost completely free from 
ether.   
55) Dissolve the peptide pellet in a minimal amount of water (1-5 ml) and flash freeze in liquid 
nitrogen before freeze drying overnight to yield a fluffy solid.    
 PAUSE POINT: Confirm the peptide identity by high resolution mass spectrometry 
(HRMS) and purity by HPLC 
 
PROCEDURE Part 3: Typical protein labelling procedure. Preparation of ligation buffer 
solution: TIMING: 10 min  
56)  
ƒ PAUSE POINT: The ligation buffer can be stored at room temperature for a few weeks before 
fresh buffer needs to be prepared.    
Preparation of stock solution: TIMING:  Variable  
The following concentrations are for a typical protein labelling reaction in our lab, but it can be varied 
depending on the scale of the reaction.   
56) Prepare a stock solution of 2 mM depsipeptide in ligation buffer and store in 1.5 ml eppendorf 
at -20 °C. 
ƒ PAUSE POINT: The depsipeptide stock solution should be stored at -20 °C, as the ester linkage is 
susceptible to hydrolysis.  
57) Prepare a solution of 120 µM protein in ligation buffer and store in a 1.5 ml eppendorf at 4 °C.   
58) Prepare a solution of 300 µM SrtA in ligation buffer and store in a 1.5 ml eppendorf at 4 °C.   
ƒ PAUSE POINT: SrtA can be stored for 2-3 weeks at 4 °C, but it can be flash frozen and stored at -80 
°C for longer periods (6 months). The enzyme still functions after several cycles of flash freezing 
without addition of a cryoprotectant.    
Typical protein labelling procedure: TIMING:  4-6 hours   
59) In a clean 1.5 ml eppendorf add 50 µL of gMBP stock (60 µM), 3 µL of SrtA stock (6 µM,  0.1 
mole equivalents, 6 µL of depsipeptide stock (120 µM, 2 equivalents) and 41 µL of ligation buffer.  
60) Thoroughly mix the ligation solution with a Gilson p200 pipette and incubate at 37 °C.  
PAUSE POINT: With larger volumes (approx. above 1 ml) it may be beneficial to agitate the ligation 
mixture to ensure complete mixing.     
61) Monitor the progress of the ligation reaction using SDS-PAGE electrophoresis, or electrospray 
mass spectrometry (ESMS). (We routinely follow protein labelling reactions in real-time using a 
standard protein mass spectrometry methods as shown in figure 3). 
PAUSE POINT: Protein modification is typically complete in 4-6 hours. However, if the ligation is 
not complete within 6 hours, add another 1.5-3 equivalents of depsipeptide substrate and increase the 
SrtA concentration to 0.2-0.3 mole equivalents. 62) Once the ligation is complete isolate the 
protein using a suitable affinity column. gMBP was isolated using a lactose-agarose affinity column. 
ǻ&5,7,&$/67(3Leaving the ligation reaction for prolonged periods will cause SrtA to hydrolyse 
the label from the modified protein. The reaction mixture should either be isolated straight away or 
flash frozen to stop the reaction.      
ƔTIMING 
  
 
TIMING 
Stage 1: Synthesis of the precursor. Preparation of Fmoc-Thr(OtBu)-Gc-OBn   
Steps 1-3: 19 hours (Overnight step) 
Purification of Fmoc-Thr(OtBu)-Gc-Obn by chromotgraphy  
Steps 4-7: 2 hours   
Preparation of Fmoc-Thr(OtBu)-Gc-OH   
Steps 8-15: 1-6 hours 
Purification of Fmoc-Thr(OtBu)-Gc-OH   
Steps 16-19: 2-3 hours; plus, overnight freeze drying step   
Part 2: Preparation of depsipeptides. Presynthesis preparation.  
Steps 20-22: 35 minutes   
LPETGcG depsipeptide synthesis.  
Steps 23-37: 1 day   
Peptide elongation.  
Steps 38-39: variable    
N-terminal fluorescent labelling using isothiocyanates. 
Steps 40-45: 20 hours (overnight step)    
Depsipeptide cleavage  
Steps 46-55: 20 hours (overnight step)    
Part 3:  
Preparation of stock solution:  
Steps 56-58-62: variable      
Typical protein labelling procedure: TIMING:  4-6 hours   
Steps 59-62: variable      
ANTICIPATED RESULTS 
Synthesis of Fmoc-Thr(OtBu)-Gc-OBn   
As described, the synthesis will typically produce 95% of product.    
Fmoc-Thr(OtBu)-Gc-OBn. Glassy Solid  
[D]D -0.4 (c 1, in CH2Cl2 at 22.7 °C) 
TLC (Hexane-ethyl acetate 2:1 v/v) RF = 0.53 
1H NMR (500 MHz, CD3OD): G 1.15 (s, 9H), 1.26 (d, J = 6.2 Hz, 3H), 4.29 (m, 2H), 4.40  (m, 3H), 
4.66 (d, J = 15.9 Hz, 1H), 4.76 (d, J =15.9 Hz, 1H,), 5.21 (s, 2H), 7.34 (m, 6H), 7.40 (m, 1H), 7.64 (m, 
1H), 7.77 (d, J = 6.2 Hz, 1H). 
13C NMR (125 MHz, CD3OD): G 21.0 (CH3), 28.5(CH3), 47.2 (CH) 59.9 (CH), 61.4 (CH2), 67.3 (CH), 
67.4 (CH2), 67.4 (CH2), 79.4 (CH), 120.1 (CH), 125.2 (CH), 127.2 (CH), 127.8 (CH), 128.5(CH), 
128.7(CH), 128.8 (CH), 141.4 (CH), 144.2 (CH), 156. 8 (C), 167.1(C), 170.6 (C). 
 IR (CH2Cl2, cm-1) 3440, 2976, 1755, 1725, 1648.  
HRMS: Found [M+Na]+ 568.2321, (calculated, for C32H35NO7Na 568.2306) 
Synthesis of Fmoc-Thr(OtBu)-Gc-OH   
Fmoc-Thr(OtBu)-Gc-OH. White lyophilisate  
[D]D -0.5 (c 1 in CH2Cl2 at 22.5 °C) 
TLC (CH2Cl2-methanol 9:1 and 1% acetic acid v/v ) RF = 0.63 
1H NMR (500 MHz,CD3OD): G 1.04 (s, 1H) 1.09 (d, J = 5.9 Hz, 1H), 4.16 (m, 2H), 4.26 (m, 1H), 
4.36 (m, 3H), 4.55 (d, J = 15.9 Hz, 1H), 7.20 (m, 1H) 7.27 (m, 1H), 7.55 (m, 1H), 7.65 (d, J = 7.6 Hz, 
1H), 
13C NMR (125 MHz, CD3OD): G 21.0 (CH3), 28.5 (CH3), 47.3 (CH), 60.3 (CH), 63.3 (CH2), 67.0 
(CH), 67.8 (CH2), 74.2 (CH), 119.9 (CH), 125.3 (CH), 127.0 (CH), 127.6 (CH), 141.3 (CH), 143.9 
(CH), 144.3 (CH), 157.6 (C), 170.5 (C),  174.1 (C). 
IR (CH2Cl2, cm-1) 3436, 3436, 2977, 1749, 1720. 
HRMS: Found [M+Na]+ 478.1837 (calculated, for C25H29NO7Na 478.1836) 
The yield of this reaction can vary significantly depending on the rate of Fmoc-protecting group 
cleavage relative to hydrogenolysis of the benzyl group. Yields have ranged from 61 ± 87%. This 
procedure can be scaled up. 
Synthesis of depsipeptide substrates    
The yields of the depsipeptide synthesis can vary depending on the sequence and length of the peptide. 
Yields have ranged from 52-89%. Expected retention time for described fluorescein-containing peptide 
in HPLC: 2.57 min. The N-terminal fluorescent labelling can be done with a range of fluorophores 
including rhodamine isothiocyanate and dansyl chloride. The depsipeptide should be able to be built on 
any base stable resin containing an N-terminal amine.  
Sortase-mediated protein modification  
The protein should be completely modified within 4-6 hours. If no protein ligation is detected then the 
protein¶s N-terminal glycine residues may be too sterically hindered for SrtA to access. If so, then an 
alternative N-terminally extended construct will be required. 
 Figure 3: Examples of monitoring protein labelling reactions in real-time by electrospray mass 
spectrometry. A Analysis by mass spectrometry of the example labelling reaction of gMBP using the 
fluorescein-labelling reagent described in this manuscript ± at this stage the reaction has not yet 
proceeded to completion. B Example of overlaid mass spectra for unlabelled gMBP (black) and 
gMBP 100% labelled with a dansyl-containing peptide (data reproduced from Williamson et al.21) 
 
?TROUBLESHOOTING  
Table 1 
Step 
Problem  Possible reason  Solution  
8 
Precipitate formation after the 
addition of H2O   
Fmoc-Thr(OtBu)-Gc-OBn 
crashing out of soloution  
Add more THF until the precipitate 
redissolves  
11 
Slow rate of hydrogenation Inefficient and/or old Pd/C catalyst    The hydrogen balloon should be removed 
from the vessel and the reaction quenched 
by flushing with nitrogen gas. Once 
quenched a further 100-300 mg of 
palladium on carbon (10 wt%)  should be 
added and the process (steps 9-11) 
repeated 
15 
Removal of solvent  Water removal can be  slow using a 
standard rotary evaporator   
The THF can be removed rapidly using 
the rotary evaporator at 40 °C, but 
removing the water can be problematic. 
To aid the removal of the water, add 
toluene to form an azeotropic solution that 
is removed more efficiently using the 
rotary evaporator at 50 °C 
55 
Depsipeptide solubility  Modified depsipeptides may be too 
hydrophobic to dissolve completely 
in water   
The addition of acetonitrile or 1,4-dioxane 
can help dissolve peptides that are not 
completely soluble in water. 
 
63 
Hydrolysis of depsipeptide 
substrate  
Under the conditions of the ligation 
reaction the depsipeptide substrate 
will slowly undergo non-enzymatic 
hydrolysis. The rate of hydrolysis 
can vary between different 
depsipeptide substrates   
If hydrolysis is a problem then 3 
equivalents of depsipeptide and 0.2 mole 
equivalents of SrtA can usually be used to 
achieve complete protein modification 
63 
Poor ligation efficiency  At very low protein concentrations 
(e.g. 10 µM) the efficiency of the 
ligation reaction can be greatly 
reduced 
Using 3-5 equivalents of depsipeptide and 
0.2-0.3 mole equivalents of SrtA will 
usually achieve complete protein 
modification 
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